Jurnal kedokteran dan kesehatan Indonesia,
Год журнала:
2024,
Номер
unknown, С. 288 - 290
Опубликована: Дек. 27, 2024
Tuberculosis
(TB),
a
disease
that
can
be
both
prevented
and
typically
cured,
likely
became
the
leading
cause
of
death
from
single
infectious
agent
again
in
2023,
after
being
surpassed
by
COVID-19
for
three
years.Tuberculosis
resulted
nearly
twice
as
many
deaths
HIV/AIDS.Each
year,
over
10
million
people
continue
to
contract
TB,
with
this
number
increasing
since
2021.Immediate
action
is
essential
eradicate
global
TB
epidemic
2030,
goal
endorsed
all
United
Nations
Member
States
World
Health
Organization.
1
Though
modern
antibiotics
like
rifampicin
isoniazid
have
been
instrumental
fight
against
emergence
drug-resistant
strains
challenges
associated
long-term
therapy
led
renewed
interest
alternative
treatments.In
2022,
it
was
estimated
around
410,000
new
cases
multidrug-resistant
or
rifampicin-resistant
tuberculosis
(MDR/RR-TB)
occurred.Over
past
years,
recent
research
into
drugs
treatment
medication
has
improvement
evaluation
several
promising
regimens
TB.
2
One
domains
exploration
herbal
medicine
potential
management
TB.Herbal
medicine,
centuries-old
practice
found
across
various
cultures,
involves
using
whole
plants
plant
extracts
curing
therapeutic
purposes.Several
traditional
remedies
known
listed
different
pharmacopoeias
world,
them
displaying
notable
antimicrobial
compounds.
35][6]
Researchers
are
progressively
devoted
investigating
these
remedies,
hoping
they
may
provide
novel
approaches
addressing
tuberculosis,
particularly
context
rapid
increase
drug
resistance.
7erbal
medicines
compounds
offer
mechanisms
could
beneficial
TB.It
might
containing
antibacterial
material
demonstrates
direct
effects
Mycobacterium
tuberculosis.These
either
destroy
bacteria
(bactericidal
effect)
inhibit
their
growth
(bacteriostatic
effect),
making
candidates
adjunctive
therapy.
3,5Another
mechanism
compound
immunomodulation,
help
modulate
immune
system
enhancing
body's
natural
defence
eliminate
bacteria.This
very
important
clearing
infection
more
effectively
reduce
risk
complications
patients
weakened
immunity,
often
suffer
other
clinical
conditions
such
HIV/AIDS
diabetes
mellitus.
1,7erbal
also
anti-inflammatory
antioxidant
materials,
so
The
absence
of
validated
correlates
protection
(CoPs)
hampers
the
rational
design
and
clinical
development
new
tuberculosis
vaccines.
In
this
review,
we
provide
an
overview
potential
CoPs
in
vaccine
research.
Major
hindrances
opportunities
are
then
discussed.
Based
on
recent
progress,
it
is
reasonable
to
anticipate
that
success
ongoing
efforts
identify
would
be
a
game-changer
development.
Microorganisms,
Год журнала:
2025,
Номер
13(3), С. 561 - 561
Опубликована: Март 1, 2025
Caulerpin,
a
bis-indole
alkaloid
isolated
from
Caulerpa
racemosa,
has
several
documented
pharmacological
activities,
including
antineoplastic
and
antiviral
properties.
This
study
aimed
to
evaluate
the
anti-inflammatory
anti-tubercular
potentials
of
caulerpin
its
analogues
in
RAW
264.7
macrophages
infected
with
Mycobacterium
spp.
Additionally,
we
evaluated
cytokine
production
NLRP3
expression
this
infection
model.
Toxicity
tests
were
performed
using
Vero
E6
HepG2
cell
lines
Artemia
salina.
Pre-incubation
cells
decreased
internalized
M.
smegmatis
tuberculosis
H37Ra.
Furthermore,
treatment
smegmatis-infected
reduced
bacterial
loads.
Caulerpin
CFU
count
bacilli
H37Ra
In
addition,
diethyl
derivative
notably
found
modulate
IL-1β
TNF-α
model
after
quantifying
pro-inflammatory
cytokines
NLRP3.
derivates
did
not
affect
viability
or
nauplii
survival
toxicity
studies.
These
findings
demonstrate
that
exhibit
activity
against
show
promising
potential
for
further
efficacy
safety
evaluation.
ACS Infectious Diseases,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 18, 2025
Tuberculosis
remains
a
major
global
health
threat,
with
traditional
antibiotic
treatments
facing
challenges
such
as
drug
resistance.
Host-directed
therapy
(HDT)
has
emerged
promising
approach
to
combat
tuberculosis
by
enhancing
the
host
immune
response.
CXCL14,
chemokine
family
member,
plays
crucial
role
in
regulating
antipathogenic
responses.
To
elucidate
of
CXCL14
and
its
key
regulatory
molecules
mycobacterial
infections,
we
identified
new
targets
for
host-directed
therapy.
RAW264.7
macrophages
were
pretreated
infected
Mycobacterium
smegmatis.
CFU,
ROS
levels,
apoptosis
assessed.
Cell
RNA
was
extracted
high-throughput
sequencing,
significantly
differentially
expressed
genes
screened
identified.
The
effects
candidate
verified
using
knockdown
overexpression
techniques.
A
mouse
model
infection
established
validate
vivo.
pretreatment
reduced
intracellular
mycobacteria
increased
levels
without
affecting
apoptosis.
Transcriptome
analysis
A20
gene.
promoted
production
decreased
mycobacteria,
while
reversed
these
effects.
combination
effectively
inhibited
survival
macrophages.
mice
organ
damage
upregulating
expression,
thereby
inhibiting
survival.
In
model,
alleviated
inflammatory
responses
histopathological
caused
infection.
These
findings
suggest
that
is
HDT
molecule
treatment
infections.
Pathogens,
Год журнала:
2025,
Номер
14(4), С. 302 - 302
Опубликована: Март 21, 2025
(1)
Background:
The
treatment
of
Mycobacterium
abscessus
(M.
abscessus)
infections
resistant
to
clarithromycin
(CLR)
is
highly
challenging.
Traditional
non-tuberculous
mycobacteria
(NTM)
chemotherapy
may
disturb
the
immune
homeostasis
host
by
increasing
oxidative
stress;
therefore,
host-directed
immunotherapy
an
alternative
option
for
caused
M.
abscessus.
(2)
Method:
A
clinical
isolate
CLR-resistant
was
screened,
and
then
therapeutic
effects
N-acetylcysteine
(NAC)
against
infection
were
evaluated
in
Tohoku
Hospital
Pediatrics-1
(THP-1)
cells
murine
models.
RNA
sequencing
Western
blot
used
profile
protective
responses
induced
NAC.
contribution
candidate
signaling
pathways
confirmed
corresponding
inhibitor
agonist.
(3)
Results:
NAC
led
a
significant
reduction
bacterial
loads
both
THP-1
models,
which
associated
with
enhanced
antioxidant
downregulation
apoptosis
signal-regulating
kinase
1
(ASK1)–mitogen-activated
protein
ki-nase/extracellular
signal-regulated
3/6
(MKK3/6)–p38
mitogen-activated
(MAPK)-mediated
inflammatory
responses.
p38
mimicked
effect
NAC,
while
agonist
attenuated
it,
suggesting
that
pathway
crucial
NAC-mediated
protection
infection.
(4)
Conclusion:
Our
study
suggests
could
be
as
therapy
agent
drug-resistant
ABSTRACT
Tuberculosis
(TB),
resulting
from
Mycobacterium
tuberculosis
(Mtb),
is
one
of
the
leading
causes
morbidity
and
mortality
in
humans
worldwide.
Host-directed
therapy
(HDT)
a
novel
approach
for
treating
TB,
particularly
those
with
drug
resistance.
Urolithin
A
(UroA)
produced
through
bioconversion
plant-derived
ellagic
acid
by
gut
microbes
has
been
proven
to
have
multiple
beneficial
effects
variety
diseases
without
showing
undesired
adverse
reactions.
However,
whether
UroA
antimycobacterial
effect
underlying
mechanism
not
yet
reported.
Here,
we
found
that
significantly
inhibited
Mtb
growth
within
both
macrophages
mice.
Moreover,
promoted
activation
autophagy
Mtb-infected
via
protein
kinase
B–Forkhead
box
O1
signaling
pathway,
which
contributed
UroA.
Additionally,
suppressed
survival
clinically
isoniazid
(INH)-resistant
(C2)
macrophages,
combination
INH
synergistically
enhanced
host
elimination
H37Rv.
Therefore,
may
be
utilized
as
potential
candidate
HDT
an
adjunctive
first-line
anti-TB
drugs.
IMPORTANCE
We
(Mtb)
macrophages.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Апрель 22, 2024
ABSTRACT
This
study
evaluated
the
efficacy
of
a
high-throughput
Dictyostelium
discoideum
–
Mycobacterium
marinum
Dd-Mm
infection
system
by
first
benchmarking
it
against
set
antibiotics
and
second
in
screening
library
natural
product
(NP)
derivatives
for
anti-infective
activity
intracellular
(Mm).
The
observed
no
pyrazinamide
Mm,
consistent
with
known
resistance
patterns,
confirmed
other
antibiotics,
such
as
rifampicin
bedaquiline,
below
defined
antibacterial
susceptibility
breakpoints.
From
small
NP
derivatives,
trans
-δ-viniferins
emerged
promising
scaffolds,
particularly
two
compounds
which
exhibited
an
on
Mm
during
but
not
broth,
17
IC
50
18.1
µM,
19
9
µM).
Subsequent
exploration
via
halogenation
structure-activity
relationship
(SAR)
studies
led
to
identification
improved
selectivity
potency.
phenotype
may
involve
mechanisms
blocking
mycobacterial
virulence
factors
or
boosting
host
defense.
Furthermore,
highlights
potential
product-inspired
derivatization
approaches
drug
discovery
underscores
utility
identifying
novel
compounds.
IMPORTANCE
significance
leveraging
innovative
models
search
By
employing
-
small,
focused
identified
scaffolds
,
opening
therapeutic
avenues
combating
tuberculosis.
findings
highlight
value
exploring
nature-inspired
chemistry
addressing
global
health
challenges.
Frontiers in Microbiology,
Год журнала:
2024,
Номер
15
Опубликована: Сен. 17, 2024
Introduction
Mycobacterium
tuberculosis
(Mtb),
the
causative
agent
of
tuberculosis,
remains
a
serious
threat
to
human
health
worldwide
and
quest
for
new
anti-tubercular
drugs
is
an
enduring
demanding
journey.
Natural
products
(NPs)
have
played
significant
role
in
advancing
drug
therapy
infectious
diseases.
Methods
This
study
evaluated
suitability
high-throughput
infection
system
composed
host
amoeba
Dictyostelium
discoideum
(Dd)
marinum
(Mm),
close
relative
Mtb,
identify
anti-infective
compounds.
Growth
Dd
intracellular
Mm
were
quantified
by
using
luminescence
fluorescence
readouts
phenotypic
assays.
The
was
first
benchmarked
with
set
therapeutic
anti-Mtb
antibiotics
then
used
screen
library
biotransformed
stilbenes.
Results
confirmed
both
efficacy
established
such
as
rifampicin
bedaquiline,
activities
below
defined
anti-mycobacterium
susceptibility
breakpoints,
lack
activity
pyrazinamide
against
Mm.
screening
revealed
promising
trans
-δ-viniferins
particular
two
compounds
17
19
IC
50
18.1
μM,
9
respectively.
Both
had
no
on
broth.
Subsequent
exploration
via
halogenation
structure-activity
relationship
studies
led
identification
derivatives
improved
selectivity
potency.
modes
action
may
involve
inhibition
mycobacterial
virulence
factors
or
boosting
defense.
Discussion
highlights
potential
biotransformation
NP-inspired
derivatization
approaches
discovery
underscores
utility
Dd-Mm
identifying
novel